224 results on '"Martinez-Hernandez, Eugenia"'
Search Results
2. Neurological adverse events related to immune-checkpoint inhibitors in Spain: a retrospective cohort study
3. Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study
4. Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
5. Clinical characterisation of patients in the post-acute stage of anti-NMDA receptor encephalitis: a prospective cohort study and comparison with patients with schizophrenia spectrum disorders
6. Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in the United Kingdom
7. CD19-Directed CAR T-Cells in a Patient With Refractory MOGAD: Clinical and Immunologic Follow-Up for 1 Year.
8. Neural signatures of reduced serial dependence in anti-NMDAR encephalitis and schizophrenia
9. MOG Antibodies Restricted to CSF in Children With Inflammatory CNS Disorders.
10. Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study
11. Neurological adverse events related to immune-checkpoint inhibitors in Spain: a retrospective cohort study
12. Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy
13. Frequency and relevance of IgM, and IgA antibodies against MOG in MOG-IgG-associated disease
14. Blocking Placental Class G Immunoglobulin Transfer Prevents NMDA Receptor Antibody Effects in Newborn Mice
15. Thymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies
16. 33 Autoimmune encephalitis
17. Frequency and Referral Patterns of Neural Antibody Studies During the COVID-19 Pandemic
18. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis
19. Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodies
20. Encephalitis and antibodies to dipeptidyl‐peptidase–like protein‐6, a subunit of Kv4.2 potassium channels
21. Author Response: Clinical Significance of Anti-NMDAR Concurrent With Glial or Neuronal Surface Antibodies
22. Clinical characterisation of patients in the post-acute stage of anti-NMDA receptor encephalitis: a prospective cohort study and comparison with patients with schizophrenia spectrum disorders (S22.006)
23. Clinical characterization and outcome of 47 patients with neurologic adverse events of immune-checkpoint inhibitors (P4-5.026)
24. Reduced serial dependence suggests deficits in synaptic potentiation in anti-NMDAR encephalitis and schizophrenia
25. Sleep disorders in anti-NMDAR encephalitis
26. Late-onset neuromyelitis optica spectrum disorder: The importance of autoantibody serostatus
27. Post-mortem neuropathologic examination of a 5-case series of CAR T-cell treated patients
28. Post-mortem neuropathologic examination of a 6-case series of CAR T-cell treated patients
29. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies
30. Motor polyradiculopathy during pembrolizumab treatment of metastatic melanoma
31. Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes
32. Telemedicine for Monitoring MS Activity and Progression
33. Encephalitis with Autoantibodies against the Glutamate Kainate Receptor (GluK2) (S41.002)
34. Neurofilament light chain levels in anti-NMDAR encephalitis and primary psychiatric psychosis (S41.005)
35. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
36. Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis
37. Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID ‐19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries
38. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
39. “Association between COVID-19 vaccination, infection, and risk of Guillain-Barre syndrome, Bell’s palsy, encephalomyelitis and transverse myelitis: a population-based cohort and self-controlled case series analysis”
40. Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2: a population-based cohort analysis
41. Antibodies to Aquaporin 4, Myelin-Oligodendrocyte Glycoprotein, and the Glycine Receptor α1 Subunit in Patients With Isolated Optic Neuritis
42. Thymoma and Autoimmune Encephalitis
43. Guillain-Barr�� syndrome after SARS-CoV-2 infection in an international prospective cohort study
44. Limitations of a Commercial Assay as Diagnostic Test of Autoimmune Encephalitis
45. Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study
46. Autoimmune Septin-5 Disease Presenting as Spinocerebellar Ataxia and Nystagmus
47. Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: incidence between 2017 and 2019 and patient profiles from 25.4 million people in six European countries
48. Seizure-related 6 homolog like 2 (SEZ6L2) autoimmunity: Neurologic syndrome and antibody effects (1802)
49. Incidence and impact of COVID-19 in a cohort of patients with myasthenia gravis from Barcelona. (4170)
50. Psychiatric and Cognitive Profile in the Post-Acute Stage of Anti-NMDA Receptor Encephalitis: A Comparative Analysis with Patients with Schizophrenia. (1806)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.